Skip to Main Content

File this under: “What were they thinking?”

Cipla, which is one of the world’s largest generic drug manufacturers, was recently cited by inspectors from the U.S. Food and Drug Administration for a litany of violations at a plant in India. But one problem stood out: the company failed to properly keep important manufacturing records and, instead had loaded bags paper scraps onto a truck and stored other bags that were earmarked for shredding.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment